2003
Requests for reprints can be addressed to:
de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Frijlink HW
Air classifier technology (ACT) in dry powder inhalation. Part 1. Introduction of a novel force distribution concept (FDC) explaining the performance of a basic air classifier on adhesive mixtures
Int J Pharm, 260, 187-200, 2003
de Boer AH, Hagedoorn P, Gjaltema D, Goede J, Kussendrager KD, Frijlink HW
Air classifier technology (ACT) in dry powder inhalation. Part 2. The effect of lactose carrier surface properties on the drug-to-carrier interaction in adhesive mixtures for inhalation
Int J Pharm, 260, 201-216, 2003
de Boer AH, Hagedoorn P, Frijlink HW
The choice of compressor for the aerosolisation of tobramycin (TOBI®) with the PARI LC PLUS® reusable nebuliser
Bolhuis GK, Eissens AC, Adrichem TP, Wesselingh JA, Frijlink HW
Hollow filler-binders as excipients for direct compression
Bosma JC, Hoffmann AC
On the capacity of continuous powder classification in a gas-fluidized bed with horizontal sieve-like baffles
Dickhoff BHJ, de Boer AH, Lambregts D, Frijlink HW
The effect of carrier surface and bulk properties on drug particle detachment from crystalline lactose carrier particles during inhalation, as function of carrier payload and mixing time
Eur J Pharm Biopharm, 56, 291-302, 2003
Diederik H, Le Brun PPH, Frijlink HW, Vitányi PMB, Weda M, Barends DM
Drug output of unvented jet nebulizers as a function of time
Eriksson HJC, Wijngaard M, Hinrichs WLJ, Frijlink HW, Somsen GW, de Jong GJ
Potential of capillary electrophoresis for the monitoring of the stability of placental alkaline phosphate
J Pharm Biomed Anal, 31, 315-357 2003
Eriksson HJC, Verweij WR, Poelstra K, Hinrichs WLJ, de Jong GJ, Somsen GW, Frijlink HW
Investigations into the stabilisation of drugs by sugar glasses: II. Delivery of an inulin-stabilised alkaline phoshatase in the intestinal lumen via the oral route
Int J Pharm, 257, 273-281, 2003
Eriksson HJC, W.L.J. Hinrichs WLJ, de Jong GJ, Somsen GW, Frijlink HW
Investigations into the stabilization of drugs by sugar glasses: III. The influence of various high-pH buffers
Pharm Res, 20, 1437-1443, 2003
van Essenberg M, Franssen EJF, van Doorne H, van Loenen AC, Boom FA
Hoe je microben er het beste buiten houdt
Frijlink HW
Benefits of different drug formulations in psychopharmacology
Eur Neuropsychopharmacology, 13, S77-S84, 2003
Rigter IM, Schipper HG, Koopmans RP, Frijlink HW, Kager PA, Guchelaar HJ
Biologische beschikbaarheid van albendazol
Westerman EM, Le Brun PPH, Touw DJ, Frijlink HW, Heijerman HGM
Sulfaat voldoet niet
Zuidema J, Bolhuis GK
Wij bleven van FPZ verstoken
Laatst gewijzigd: | 09 januari 2020 10:18 |